Could Shelter Cats Be Silent Carriers of SARS-CoV-2? New Study Finds Surprising Results!
A new study reveals the potential role of shelter cats in harboring SARS-CoV-2 and possibly a related virus variant, highlighting concerns for public health and animal-to-human transmission.
Mixlab Expands Midwest Operations with the Acquisition of The Pet Apothecary and SBH’s Veterinary Business
Mixlab, the leading modern veterinary pharmacy, has acquired The Pet Apothecary, a Wisconsin-based local pet pharmacy, and the veterinary business of SBH Medical, an Ohio-based compounding pharmacy, with continued financial backing from Vanterra Ventures joined by PLUS Capital. These strategic acquisitions mark a significant expansion of Mixlab’s footprint in the Midwest, tripling its network of veterinary partners in the region. Mixlab will leverage its proprietary technology platform and streamlined processes to create a better pharmacy experience, and fuel continued growth.
Why Are 39% of Cat Owners Not Giving Their Pets Medication? Study Reveals Shocking Reasons!
A recent study uncovers the reasons behind cat owners’ struggles with medication compliance, highlighting key factors that affect the administration of prescribed treatments and how veterinarians can improve outcomes.
Can an Anomaly in Dog's Spine Cause Hip Dysplasia? New Study Unveils Surprising Link
Explore how an asymmetric lumbosacral transitional vertebra (LTV) may affect dog's pelvis and contribute to hip dysplasia. A new study reveals important insights into the link between this congenital anomaly and canine health.
Resilience in the Face of Fire: How California’s Wildfires Are Impacting Animals and the Heroes Helping Them
California wildfires have long been a source of devastation for both humans and animals, and this year’s fires have hit hard yet again. In the January 13, 2025, episode of Vet Candy, we focus on the toll these wildfires are taking on animals, how veterinarians are stepping up to help, and the ways the community is coming together to provide critical aid.
FDA Solicits Public Comments on Use of Cannabis-Derived Products in Veterinary Medicine
The U.S. Food and Drug Administration’s Center for Veterinary Medicine has released a request for information (RFI) soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDP) in animals. The focus of this RFI is on cannabidiol (CBD) products and other products derived from hemp. The FDA is interested in general trends associated with these products, such as information about usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns.

